|
|
 |
BUTYLPARABEN Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
CARBOMER 934 Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
CELLULOSE ACETATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
CABOMETYX Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
CANDELILLA WAX Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|